A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Orbactiv® (Oritavancin) for Infections Caused by Gram Positive Bacteria in a Real World Setting
Clinical trial NCT03159403 · COMPLETED
Trial details
- NCT number
- NCT03159403
- Sponsor
- Melinta Therapeutics, Inc.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-04-12
- Primary completion
- 2018-02-15
- Enrollment
- 325
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.